Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins. How these vaccines work and why they are only effective in some patients remains unclear. Pierre Coulie and colleagues now show, in two articles in the January 17 issue of the Journal of Experimental Medicine, that these vaccines work by increasing the number of immune cells called killer T cells that can attack the tumor. In an unexpected finding, however, they discovered that that these cells mostly recognize tumor proteins that were not contained in the vaccine. Understanding the characteristics of the T cell populations that are expanded after vaccination may help in the development of more effective anti-tumor vaccines.
Tumor-specific T cells can be detected in the blood and the tumors of many melanoma patients, and yet these cells are unable to kill the tumor. What causes the impotence of these T cells is a mystery. Equally mysterious is why vaccination against tumor-specific proteins sometimes causes tumor regression without expanding large numbers of vaccine-specific killer T cells.
Pierre Coulies group studied anti-tumor T cells in patients vaccinated with a tumor antigen called MAGE-3. In one patient whose tumor regressed after vaccination, the authors found significantly more T cells specific for non-vaccine tumor proteins than were detected before vaccination. Vaccine-specific T cells, on the other hand, became detectable but did not expand to large numbers. Thus, reinvigoration of existing tumor-specific T cells after vaccination did not require large numbers of vaccine-specific T cells.
Although it is not known how these tumor-specific cells get activated, Coulie thinks that the few T cells stimulated by the vaccine may change the local, suppressive environment of the tumor such that other T cells can snap out of their stupor and attack the tumor.
Nickey Henry | Source: EurekAlert!
Further information: www.rockefeller.edu
www.jem.org
More articles from Life Sciences:
Genome sequence for the domestic horse to be unveiled
06.11.2009 | University of California - Davis
Common plants can eliminate indoor air pollutants
06.11.2009 | American Society for Horticultural Science
Airborne nitrogen shifts aquatic nutrient limitation in pristine lakes
06.11.2009 | Studies and Analyses
Genome sequence for the domestic horse to be unveiled
06.11.2009 | Life Sciences
06.11.2009 | Earth Sciences
Texas Tech University Hosts Major Textile Conference in India
06.11.2009 | Event News
Brief Highlights of the Fluid Dynamics Conference, Minneapolis
30.10.2009 | Event News
EUROSAFE Forum 2009 Brussels: "Safety Implications of an Increased Demand for Nuclear Energy"
29.10.2009 | Event News